Is FMYR or MRK a better dividend investment in 2026?

FMYR currently yields 1666666.67% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: FMYR offers higher current income.

What is the dividend yield difference between FMYR and MRK?

FMYR has a forward dividend yield of 1666666.67% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 1666663.91 percentage points.

Home › Compare › FMYR vs MRK

FMYR vs MRK: Dividend Comparison 2026

FMYR yields 1666666.67% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FMYR wins by $7.881388007847456e+38M in total portfolio value

INVESTMENT

TIME HORIZON10 years

FMYR

● Live price

1666666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7.881388007847456e+38M

Annual income

$788,045,788,464,202,500,000,000,000,000,000,000,000,000,000.00

Full FMYR calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — FMYR vs MRK

📍 FMYR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	FMYR	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, FMYR + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

FMYR pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FMYR

Annual income on $10K today (after 15% tax)

$141,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$669,838,920,194,572,100,000,000,000,000,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, FMYR beats the other by $669,838,920,194,572,100,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FMYR + MRK for your $10,000?

FMYR: 50%MRK: 50%

100% MRK50/50100% FMYR

Portfolio after 10yr

$3.940694003923728e+38M

Annual income

$394,022,894,232,101,200,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FMYR

No analyst data

Altman Z

-6.3

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FMYR buys

MRK buys

No recent congressional trades found for FMYR or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricFMYRMRK

Forward yield	1666666.67% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$7.881388007847456e+38M	$56.8K ✓
Annual income after 10y	$788,045,788,464,202,500,000,000,000,000,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$7.881327152392866e+38M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: FMYR vs MRK ($10,000, DRIP)

Year	FMYR Portfolio	FMYR Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$166,677,367	$166,666,666.67	$11,206	$366.19	+$166.67M → FMYR
2	$2,596,399,009,372	$2,596,220,664,589.82	$12,650	$502.35	+$2596399.00M → FMYR
3	$37,799,368,960,870,740	$37,796,590,813,930,710.00	$14,407	$694.19	+$37799368960.86M → FMYR
4	$514,299,522,501,000,700,000	$514,259,077,176,212,500,000.00	$16,585	$967.82	+$514299522501000.69M → FMYR
5	$6,539,827,688,394,773,000,000,000	$6,539,277,387,905,697,000,000,000.00	$19,342	$1,363.89	+$6539827688394772480.00M → FMYR
6	$77,720,443,582,794,890,000,000,000,000	$77,713,445,967,168,310,000,000,000,000.00	$22,913	$1,947.19	+$7.772044358279489e+22M → FMYR
7	$863,223,381,090,722,600,000,000,000,000,000	$863,140,220,216,089,000,000,000,000,000,000.00	$27,662	$2,823.89	+$8.632233810907226e+26M → FMYR
8	$8,960,459,278,400,958,000,000,000,000,000,000,000	$8,959,535,629,383,190,000,000,000,000,000,000,000.00	$34,159	$4,173.35	+$8.960459278400959e+30M → FMYR
9	$86,927,402,376,655,070,000,000,000,000,000,000,000,000	$86,917,814,685,227,190,000,000,000,000,000,000,000,000.00	$43,337	$6,308.80	+$8.692740237665508e+34M → FMYR
10	$788,138,800,784,745,600,000,000,000,000,000,000,000,000,000	$788,045,788,464,202,500,000,000,000,000,000,000,000,000,000.00	$56,776	$9,798.13	+$7.881388007847456e+38M → FMYR

FMYR vs MRK: Complete Analysis 2026

FMYR — Stock

Family Room Entertainment Corporation, together with its subsidiaries, provides development, production, co-production and production, distribution, and consulting services for the motion picture entertainment industry in the United States. It also contracts with third parties or joint ventures for the distribution and/or exploitation of wholly owned and controlled entertainment properties and/or arrangements. The company was formerly known as Cobb Resources Corporation and changed its name to Family Room Entertainment Corporation in 2000. The company was founded in 1969 and is based in Toluca Lake, California. Family Room Entertainment Corporation is a subsidiary of Qin Media Limited.

Full FMYR Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this FMYR vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FMYR vs SCHD FMYR vs JEPI FMYR vs O FMYR vs KO FMYR vs MAIN FMYR vs JNJ FMYR vs ABBV FMYR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.